Skip to content

Efficacy of precise repetitive transcranial magnetic stimulation therapy for Major depressive disorder and the effects on cognitive function

Efficacy of precise repetitive transcranial magnetic stimulation therapy for Major depressive disorder and the effects on cognitive function - The effect of precise rTMS on the efficacy and cognitive function of MDD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075761
Enrollment
Unknown
Registered
2023-09-14
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

Routine rTMS intervention group:The intervention target of rTMS was determined by the empirical "5cm rule". The hot spot in the left movement area was moved forward by 5cm as the site of the left DLPF
Precision rTMS intervention group:Magnetic resonance scanning was used for accurate positioning, and the [-44,36,20] position of MNI coordinates was selected as the cortical precise target to be inter
Pseudo-stimulus rTMS intervention group:The appearance and sound of the pseudo-coil and the treatment coil are difficult to distinguish, but the actual magnetic stimulation intensity is far below the

Sponsors

Shanghai Pudong New Area Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for depression in ICD-10 (outpatient patients need to be clinically diagnosed by two physicians with a title of attending or above); 2. Agree to receive rTMS treatment; First or recurrent, the duration of the attack =3 years; 3, age 18-65 years old; Junior high school or above; 4. This attack failed to respond to a full dose of SSRI antidepressant for 4 weeks or was intolerant to at least one antidepressant; 5. Score of HAMD-17 item scale =17 points; 6. The dose of medication did not change in the first 2 weeks of enrollment.

Exclusion criteria

Exclusion criteria: 1within the last three months, drug or alcohol dependence and other effects on cognitive function; 2, have serious physical diseases, cardiac pacemakers or implanted drug pumps; 3, have serious negative ideas and behaviors; 4, pregnant women; 5. Treatment with ECT is ineffective; 6, any neurological diseases, including intracranial injury, epilepsy, Parkinson's disease, etc. 7. There are metal implants in the skull; Use of anticonvulsant drugs; 8. Use of benzodiazepines within 12 hours and alcohol within 8 hours prior to the cognitive test.

Design outcomes

Primary

MeasureTime frame
HAMD-17;the THINC-it tool;

Secondary

MeasureTime frame
HAMA-14;Dimensional Anhedonia Rating Scale;Pittsburgh Sleep Quality Index;

Countries

China

Contacts

Public ContactZhu Na

Shanghai Pudong New Area Mental Health Center

zhuna1987524@aliyun.com+86 137 6140 8662

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026